Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Accumulated Expenses (2022 - 2025)

NewGenIvf (NIVF) has disclosed Accumulated Expenses for 4 consecutive years, with $514169.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 410.08% to $514169.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $514169.0 through Dec 2025, up 410.08% year-over-year, with the annual reading at $514169.0 for FY2025, 410.08% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $514169.0 at NewGenIvf, up from $100802.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $514169.0 in Q4 2025, with the low at $43633.0 in Q4 2023.
  • Average Accumulated Expenses over 4 years is $194134.8, with a median of $109368.5 recorded in 2022.
  • The sharpest move saw Accumulated Expenses crashed 63.0% in 2023, then skyrocketed 410.08% in 2025.
  • Over 4 years, Accumulated Expenses stood at $117935.0 in 2022, then plummeted by 63.0% to $43633.0 in 2023, then soared by 131.02% to $100802.0 in 2024, then surged by 410.08% to $514169.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $514169.0, $100802.0, and $43633.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.